Abstract

Background: Thyroid functions are affected in chronic kidney disease by multiple ways. The decline in kidney Function is accompanied by changes in the synthesis, secretion, metabolism and elimination of Thyroid hormones. The study is planned to determine the correlation between severities of chronic Kidney disease and the status of thyroid function. Objectives: To study the biochemical abnormalities of thyroid function tests in CKD patients and to study the correlation between thyroid dysfunction and severity of renal diseases. Materials and Methods: The study was carried out among patients visiting the Department of General Medicine and Nephrology at tertiary care centre Bengaluru, for a period of 18 months. 50 CKD patients satisfying the inclusion and exclusion criteria were included in the study. Blood urea, serum creatinine and thyroid Profile was done in all the 50 patients. Estimated - GFR was calculated by MDRD formula staging was done according to KDIGO classification. The thyroid parameters were studied in various stages of CKD and correlation studies were done for eGFR with each of the thyroid parameters. Results: Majority of the patients belonged to 61-70 years age group & 62% were males & 38% were females. Overall 60% of the CKD patients had thyroid abnormalities among which 30% had low T3 syndrome, 16% had subclinical hypothyroidism, 14% had overt clinical hypothyroidism and 40% were euthyroid. When the distribution of these thyroid abnormalities were analyzed in relation to different CKD stages it is found that as the CKD stage progressed number of patients with different thyroid abnormalities also increased. 60% of the patients with thyroid abnormalities belonged to stage 5, 30% belonged to stage 4 while remaining 10% belonged to stage 3, Further correlation between TSH and GFR was analysed, it showed a inverse relationship with correlation coefficient [r] of -0.342 with P value of 0.0007 which is statistically significant stating that as the e-GFR decreased TSH increased. When correlational studies were done for e-GFR with FT4 and FT3 levels, they showed a positive correlation, with correlation coefficient [r] of 0.377 with P value of 0.003 in case of FT4 and coefficient [r] of 0.352 with a P value of 0.006 in case of FT3, both of which was statistically significant stating that as the e-GFR decreases FT3 and FT4 also decreases. Conclusion: Patients with CKD are at increased risk of developing Thyroid dysfunction either in the form of low T3 syndrome, subclinical or clinical hypothyroidism and is more significant as the stage of CKD progresses.

References

1. Coresh J, Selvin E and Stevens LA. Prevalence of chronic kidney disease in the United States. JAM 2007; 298(17):2038-47.
2. Hosseinpanah F, Kasraei, F, Nassiri AA, and Azizi F. High prevalence of chronic kidney disease in Iran: A large population based study. B MC Public health 2009; 9:44-52.
3. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, and Rosset, J. Definition and Classification of Chronic Kidney Disease: a positive statement from kidney disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67(6):2089-100.
4. Iglesias P and Diez JJ. Thyroid dysfunction and kidney disease. European journal of endocrinology 2009; (160):503-15.
5. Abozenah H, Shoeb S, Sabry A and Ismail H. Relation between thyroid hormonal concentration and serum levels of interleukin-6 and interleukin-10 in patients with Non-thyroid illness including chronic kidney disease. IJKD 2008; (2):16-23.
6. Lim VS. Thyroid function in patients with chronic renal failure. Am J Kidney Dis 2001; 38:80-84.
7. Chonchol M, Lippi G, Salvagno G, Zoppini G, Muggo M and Targher G. Prevalence of subclinical Hypothyridism in patients with Chronic kidney Disease. Clin J Am Nephrol 2008: (3); 1296-1300.
8. Lo JC, Chertow MG, Go AS and Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney international 2005; 67:1047-52.
9. Joan CL, Glenn M, Chertow, Alan A, and Chi-yuan H;. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease; Kidney International, 2005; Vol. 67: pp. 1047–1052
10. Asif M, Akram M, Ullah A. Chronic kidney disease; correlation between free thyroxin, thyrotrophin and glomerular filtration rate. Professional Med J 2013;20(4): 506-512.
11. Lin Y, Tarng D. Abnormal thyroid function in peritoneal dialysis patients: Lots of smoke but no fire. Journal of the Chinese Medical Association. 2012;75(2):47-48.
12. Lo JC, Chertow MG, Go AS and Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney international 2005; 67:1047-52
13. Enia G, Panuccio V, Cntupi S, Pizzim P, Tripepi G and Mallamaci F et al. Subclinical hypothyroidism is linked to microinflammation and predicts death in continuous ambulatory peritoneal dialysis. Dial Transplant 2007; (22):538-54.
14. Lo JC, Chertow MG, Go AS and Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney international 2005; 67:1047-52.
15. Alsaran K, Sabry A, Alshahat H, Babgy E and Alzaharani F. Free thyroxine, free triiodothyronine and thyroid stimulating hormone before and after hemodialysisin Saudi patients with end stage renal disease: Isthere any difference? Saudi J Kidney Dis Transpl 2011;22(5):917-21
16. Joanne M.B, Karl S, Chronic kidney disease, Harrison’s principles of internal medicine, 19th edition, part 13, chapter 335.
17. Suresh C and Sanjay K.A, Incidence of chronic kidney disease in India, Nephrol. Dial. Transplant; 2006 21(1):232-233.
18. Knochell.JP, Endocronic changes in patients on chronic dialysis, In: replacement of function by dialysis”, W. Drukker, FM Parsons, JF Maher, editors, 2nd edition, Boston: Martinus Nijhoff publishers; 1983; 712-723.
19. De Groot LJ: Dangerous Dogmas in Medicine: The non thyroidal illness syndrome, J. Chin endocrine metabol 1999; 84: 151-164.
20. Lim VS: Thyroid function in patients in CRF; Am J Kidney disease 2001;38(Supplement 1): 880-884.
21. Lo JC, Cherton GM, Go AS, HSU CY: Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease, Kidney Int 2005;67(3):1047-1052.
22. Mehta HJ, Joseph LJ, Desai KB, Mehta MN, Samuel AM, Almeida AF, Acharya VN. Total and free thyroid hormone levels in chronic renal failure. J Postgrad Med 1991;37:79-83
23. Domenico S, Terry F, Davies, Martin S, Ian D. Hay, R Larsen; Thyroid Physiology and Diagnostic Evaluation of Patients with Thyroid Disorders. Williams textbook of endocrinology 12edn. 2011; chapter 11:327-361
24. Larsen PR, Ingbar SH, Kronenberg, The Thyroid Gland; Text book of Endocrinology, 12th edtn 389- 498.
25. Utinger GJ, Manowitz NR, Mayor G, Ridway CE, The Colorado thyroid disease prevalence study. Arch Intern Med, 2000: 160; 526-34.
26. J, Larry Jameson, Anthony P, Weetman, Disorders of the thyroid gland, Harisson’s Endocrinology 2010; 2nd edn; chapter 4; 62-98.
27. Gregory A B, Terry F. Davies; Hypothyroidism and Thyroiditis; Williams Textbook of Endocrinology 12edn, 2011; chapter 13 406- 429:
28. Canaris DS. Subclinical hypothyroidism. N Engl J Med 2001: 345; 260-65.
29. Cooper DS. Subclinical hypothyroidism. N Engl J Med 2001: 345; 260-65.
30. Dickman T, Lansberg PJ, Kastelein JJP, Weirsinger WM. Prevalence and correlating hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Int. Med, 1995: 155; 1490-95.
31. Coopan R, Kozak GP, Hyperthyroidism and diabetes mellitus, Arch Intern Med 1980: 140; 370-3.
32. Dal G, Levyo, Carrasco N. Cloning characterization of the thyroid iodide transporter, Nature 1996: 379; 458-60.
33. Immunoradiometric assay protocol (IRMAK-9) Board of Radiations Isotope technology, Vashi complex, Navi Mumbai.
34. Anastassios G, Pittas, Stephanie L, Lee; Evaluation of Thyroid Function; Handbook of Diagnostic Endocrinology 2003, chapter 6; 107-155
35. Shah NF, Tests of thyroid function, JAPI 2000: 48; 51, 15-18.
36. Spitzzweg C, Morris JC; The immune response to the iodide transporter. Endocrinal MetabClin North Am 2000; 29: 389-98.
37. Staub JI, Althaus BU, Englor H, Ruff AS et al. Spectrum of subclinical and overt hypothyroidism Am J Med 1992: 92; 631-42.
38. Ayala AR, Danese MP, Ladenson PW. When to treat mild hypothyroidism. Endocrinal metabClin North Am J 2000: 29, 2; 399-415.
39. Custro N et al., Prospective study on thyroid function anomalies in seriously ill patient. Ann Ital med Int, 1992; 7:8-13.
40. Hasegawa K et al. Abnormal response of thyrotrophin and growth hormone to thyrotrophin releasing hormone in chronic renal failure. Acta Endocrinol1975; 79:635– 43.
41. Ramirez G et al. Thyroid dysfunction in uraemia. Evidence for thyroid and hypophyseal abnormalities. Ann Inter med 1976 84:672-6.
42. Silverberg DS et al. Effect of chronic hemodialysis on thyroid function in chronic renal failure. Can Med An 1973; 109:282 – 6.
43. Weissel M et al. Basal and TRH stimulated Thyroid and Pituitary hormones in various degree of renal insufficiency. Acta Endocrinol,1979; 90:23 – 32.
44. Dandona P et al. Thyroid function in chronic renal failure. Proc Eur Dial transplant Assoc, 1976; 12:268 – 71.
45. Hegedus L et al. Thyroid gland volume and serum concentrations of thyroid hormone in chronic renal failure. Nephron, 1985; 40:171 – 4.
46. Kaptein E et al. Thyroid function in renal failure. Contrib Nephrol, 1986; 50:64 – 72.
47. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am. J. Kidney Dis. 2002; 39 (2 Suppl 1):S1-S266.
48. Brenner: Pathogenesis of Renal Disease; Brenner and Rector's The Kidney, 8th ed 2007 chapter 32; 705-729.
49. All India CKD registry of the Indian Society of Nephrology.
50. Robert GL, Chronic renal failure, CECIL Text Book of medicine, 21st edn.,571 78.
51. Kalz IA, Emmanovel DS, Lindheimer MD, Thyroid hormone and the kidney. Nephron 1975;15:223-249
52. Kautras DA, Maekat SG, Riagopulos GA, Malamos B. Iodine metabolism in CRF; Nephron 1972; 9:55-65.
53. Robertson BF, Prestwich S, Ramirez G et al., The role of iodine in the pathogenesis of thyroid enlargement in patients with CRF: J Clin Endocrinolmetab 1983; 57:181.
54. Thyroid dysfunction in uremia: Evidence for thyroid and hypophyseal abnormalities Ann Intern med 1976; 84:672-676.
55. Kaptein EM, Quion-verde H, Chooljian CJ: The thyroid in end-stage renal disease. Medicine (Baltimore) 1988; 67:187–197, 44. J. J. Carrero1 et al., J of Int Med 1988; 262; 690–701
56. C Zoccali1, F Mallamaci1, G Tripepi1, S Cutrupi1 and P Pizzini; Kidney International, 2006; 70, 523–528.
57. Carmine Z, Giovanni T, Sebastiano C, Patrizia P, Francesca M; J Am SocNephrol 2005;16: 2789–2795.
58. Hardy MJ. Ragbeer SS, Nascrimnto L. Pituitary Thyroid Function in CRFassessed by a highly sensitive thyrotropin assay. J clin Endo Met lab 1988: 66:233-236.
59. Mujais SK, Sanitini S, Kurtzman NA, Pathophysiology of uremic syndrome. In: “The Kidney”, Brenner, FC Rector, Editors. Philadelphia: WB Saunders Company: 1986, pp 1587- 1630.
60. Silverberg DS, Ulan RA, Faweett DM. Dossetor JB, Grace M, Beitcher K. Effects of Chronic haemodialysis on thyroid function in CRF. Can med assoc J 1974:109: 282- 286.
61. Bartalena L et al., (1990). Lack of nocturnal serum Thyrotropin surge in patients with chronic renal failure undergoing regular maintenance hemofiltration; a case of central hypothyroidism. Clinical Nephrology, 34: 30 – 4.
62. Carter JN et al., (1977). Effects of triiodothyronine administration in patients with chronic renal failure. AustNz J Med, 7:612 – 6.
63. Hardy MJ et al. (1988) Pituitary –Thyroid function in chronic renal failure assessed by a highly sensitive thyrotropin assay; J clin Endocrinol metab, 66:233-6.
64. Amato et al., Thyroid hormone action in chronic kidney disease: Current Opinion in Endocrinology, diabetes& obesity; Oct 2008-vol 15; issue 5-p 459-465
65. Spector DA et al., (1976). Thyroid function and metabolic rate in chronic renal failure. Ann Intern Med. 85:724 – 30.
66. Harrison’s principles of internal medicine, 19th edition, Disorders of lipoprotein metabolism, part 16.421
67. Rober W. Schrier, Manual of Nephrology, 6th edition; page:25.
68. Michel Chonchol, Giuseppe Lippi, GianlucaSalvagno, Giacomo Zoppini, Michele Muggeo, and Giovanni Targher;Clin J Am SocNephrol 2008 3:1296–1300,.
69. La Franchi S et al., (1991). Thyroid function in children with renal failure. J Pediatr. 118:896 – 8.
70. Gaskin JH, (1976). Thyroid gland in uraemia. Am Intern Med.85:680 – 1.
71. Chopra IJ, Chopra U, Smith, SR, Reza M,Solomen DH. Reciprocal changes in serum concentrations of 3, 3’, 5 triiodothyronine (reverse T3) and 3, 3’, 5 triiodothyronine (T3) in systemic illnesses. J Clin Endocrinol Met 1975; 41:1043- 1049.
72. Lim VS, Fang VS, Katz AI, Refetoff S. Thyroid dysfunction in chronic renal failure. A study of the pituitary thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J Clin Invest 1977; 60:522-534.
73. Silverberg DS et al. Effect of chronic hemodialysis on thyroid function in chronic renal failure. Can Med An, 1973;109:282 – 6.
74. G Avasthi, S Malhotra, APS Narang, S Sengupta; Study of thyroid function in patients of chronic renal failure; Indian J Nephrol 2001;11: 165-169
75. Lindner A, Charna B, Sherrard DS, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Eng J med 1974: 290:697-701
76. Stenvinker L et al.: Strong association between malnutrition, inflammation and atherosclerosis in CRF. Kidney int 1999; 55: 1899-1911.
77. Cheung AK, Sarnalk MJ, Yan G, Dwyer JT, Heyka RJ, Roceo Mu et al.: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients; Kidney Int 2000; 58:353-362.
78. Rodrigues et al.; Thyroid Hormone Transport is Disturbed in Erythrocytes from Patients with Chronic Renal Failure on Hemodialysis; Renal Failure, 2004, Vol. 26, No. 4: Pages 461-466
79. Ron Hogg; Textbook of Kidney disorders in children and adolescents: a global perspective of clinical practice- “Effect of kidney disorders on endocrine system” 2006 chapter 17;203-211
80. Savdie E, Stewart JH, et al. Circulating thyroid hormone levels and adequacy of dialysis. ClinNephrol 1978; 9:68-72
81. Pagliacci MC, et al. Thyroid function tests in patients undergoing maintenance dialysis: Characterisation of 'Low T4 Syndrome' in subjects on regular haemodialysis and continuous ambulatory peritoneal dialysis. Nephron 1987; 46: 225-230.
82. Dudani RA, Desai KB, Mehta MN, Mani LS, Acharya VN. Thyroid dysfunction in uremia. J Assoc Phys India 1981; 29: 1038-1040
83. Karunanidhi A, Kanagasabapathy AS, Shastry JCM, Koshi TS. Thyroid function in patients with chronic renal failure. Ind J Med Res 1979; 69
84. Hollander JG, Wulkan RW, Mantel MJ, Berghout A.; Correlation between severity of thyroid dysfunction and renal function; Clin Endocrinol.; 2005 Apr;62(4):423-7.
85. Subhashish A, Michael GS, H Kramer, Aditya J, David MH. The Association of Chronic Kidney Disease and Metabolic Syndrome with Incident Cardiovascular Events: Multiethnic Study of Atherosclerosis; Cardiology Research and Practice 2011;Vol 2012; p 1-8.
86. Robert G luke, Chronic renal failure, CECIL TB of medicine, 21s t edn., 571-78.
87. Malhotra KK: Chronic renal failure. API TB of medicine, 7t h edn., 695-99.
88. Kaptein EM et al.; The thyroid in end stage renal disease. Medicine, 1988: 67; 187.
89. Procci WR et al.: sexual dysfunction in the male patients with uremia; A reappraisal. Kid. Int., 1981: 19; 317.
90. Tyler HR: Neurological disorders seen in uremic patients. Arch. Intern Med, 1970: 126; 781-86.
91. Erslev AJ; Anemia of Chronic renal disease Arch. Intern Med, 1970: 126; 774-80 89. Chonchol M, Lippi G, Salvagno G, Zoppini G, Muggeo M, Targher G. Prevalence of Subclinical Hypothyroidism in Patients with Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology. 2008;3(5):1296-1300.
92. Zoccali C, Mallamaci F. Thyroid Function and Clinical Outcomes in Kidney Failure. Clinical Journal of the American Society of Nephrology. 2011;7(1):14.